Local control and postponement of systemic therapy after modest dose radiotherapy in oligometastatic myxoid liposarcomas

CONCLUSIONS: This trial suggests that 36Gy could possibly be effective to achieve local control, postpone systemic therapy and reduce symptoms in oMLS. Given the minimal toxicity this treatment could be reasonably considered in oMLS.PMID:33610624 | DOI:10.1016/j.radonc.2021.02.013
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - Category: Radiology Authors: Source Type: research